⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
SRPT News
Sarepta Therapeutics,, Inc. Common Stock
Qualifacts Showcases AI Innovations, Interoperability, and Data Advancements at NatCon26
globenewswire.com
GH
SRPT
WLY
When Science Becomes an Asset: How Advancing Drug Pipelines Are Driving Real-Time Valuation in Biotech
globenewswire.com
SRPT
ALNY
DNLI
ARCT
Centri Announces Panel Topics and Featured Programming for Second Annual Capital Conference at Nasdaq on April 14
accessnewswire.com
NDAQ
DFIN
PTGX
STRL
TNDM
AXSM
CSTL
CYTK
GILD
INSM
KODK
NBIX
OCGN
REGN
SRPT
VRTX
XBIT
AMZN
GOOGL
MSFT
NVDA
IBM
ORGN
BWEN
CCJ
EXC
NEE
SO
UTL
XOM
BALY
OXY
PBF
CHRD
AX
BAC
MAXN
PHIO
KZR
SMX
DUOT
COIN
EHTH
Sarepta Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
businesswire.com
SRPT
Sarepta Announces First Clinical Data from siRNA Pipeline Targeting FSHD1 and DM1
businesswire.com
SRPT
Sarepta to Share First Clinical Data from siRNA Pipeline Targeting FSHD1 and DM1
businesswire.com
SRPT
Sarepta Provides Regulatory Update on AMONDYS 45 ® and VYONDYS 53 ®
businesswire.com
SRPT
Sarepta Announces that Screening and Enrollment are Underway in ENDEAVOR Cohort 8 to Evaluate Enhanced Immunosuppression Regimen as Part of ELEVIDYS Gene Therapy for Non-Ambulant Individuals with Duchenne
businesswire.com
SRPT
Amondys 45 (casimersen: Sarepta Therapeutics) Market Research Report 2026: Epidemiology, Pipeline Analysis, Trends, Strategies, & Forecasts, 2020-2025, 2025-2030F, 2035F
globenewswire.com
SRPT
PPMD Joins Cooperative International Neuromuscular Research Group, Global Sponsors to Advance Expanded Duchenne Natural History Study
prnewswire.com
SRPT
SLDB